FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
Links shared publicly online about this topic.
- 0total visits
FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
fda.gov —
[11-01-2011] The U.S. Food and Drug Administration (FDA) is updating the public that a large, recently-completed study in children and young adults treated with medication for Attention-Deficit/Hyperactivity Disorder (ADHD) has not shown an association between use of certain ADHD medications and adverse cardiovascular events.
View full resource at fda.gov
Tags: Heart, ADHD, ADHD Medication, Drug, Children's Health, FDA, Event
Most Recently Shared on November 1, 2011 at 4:50 pm By:
No link between children ADHD drugs and cardiovascular events, FDA says. http://t.co/8tYTnFdt
Advertisement
